<unk> <unk><unk><unk>  (A1AD) is more common in people of Northern European, Iberian, and Saudi Arabian descent. Most researchers believe it is markedly underrecognized. The incidence of<unk> <unk><unk><unk>  (A1AD) is estimated to be 20 cases per<unk> 00,000 individuals worldwide. The prevalence of<unk> <unk><unk><unk>  AATD is estimated to be 70,000-100,000 cases annually.<unk><unk><unk><unk>  (AATD) is one of most common lethal genetic diseases among adult white population.<unk><unk><unk><unk>  AATD has estimated<unk> 17 million carriers and 3.4 million affected individuals. AATD is more prevalent among the white population.<unk> <unk><unk><unk>  (A1AD) is more common in people of Northern European, Iberian, and Saudi Arabian descent. Most researchers believe it is markedly under-recognized. Men and women are affected equally by AATD.
Alpha 1-antitrypsin deficiency epidemiology and demographics
Bronchiectasis epidemiology and demographics
Chronic bronchitis epidemiology and demographics
Acute bronchitis epidemiology and demographics
Bronchitis epidemiology and demographics
Tracheitis epidemiology and demographics
Asthma epidemiology and demographics
Bronchiolitis epidemiology and demographics